DENTSPLY SIRONA Inc. (XRAY) has a negative trailing P/E of -3.9, meaning the company is currently unprofitable on a trailing twelve-month (TTM) basis. The forward P/E of 8.5 based on analyst estimates suggests a return to profitability is expected. Trailing earnings yield is -25.53%, forward earnings yield 11.72%. PEG 1.18.
Criteria proven by this page:
Overall SharesGrow Score: 32/100 with 1/7 criteria passed.
| Year | P/E (TTM) | PEG Ratio | P/B Ratio | P/S Ratio | Dividend Yield |
|---|---|---|---|---|---|
| 2016 | 29.3 | 2.91 | 1.55 | 3.36 | 0.51% |
| 2017 | -9.7 | 0.02 | 2.28 | 3.78 | 0.52% |
| 2018 | -8.3 | 0.24 | 1.63 | 2.09 | 0.94% |
| 2019 | 49.3 | -0.39 | 2.48 | 3.14 | 0.64% |
| 2020 | -157.2 | 1.19 | 2.33 | 3.44 | 0.77% |
| 2021 | 29.6 | -0.05 | 2.44 | 2.88 | 0.76% |
| 2022 | -7.2 | 0.02 | 1.80 | 1.75 | 1.52% |
| 2023 | -57.2 | 0.67 | 2.29 | 1.90 | 1.54% |
| 2024 | -4.2 | -0.01 | 1.99 | 1.02 | 3.27% |
| 2025 | -3.8 | 0.12 | 1.70 | 0.62 | 5.62% |
| Year | EPS (Diluted) | Revenue | Net Income | Net Margin |
|---|---|---|---|---|
| 2016 | $1.94 | $3.75B | $429.9M | 11.5% |
| 2017 | $-6.86 | $3.99B | $-1.57B | -39.4% |
| 2018 | $-4.51 | $3.99B | $-1.01B | -25.4% |
| 2019 | $1.17 | $4.03B | $262.9M | 6.5% |
| 2020 | $-0.38 | $3.34B | $-83M | -2.5% |
| 2021 | $1.87 | $4.25B | $411M | 9.7% |
| 2022 | $-4.41 | $3.92B | $-950M | -24.2% |
| 2023 | $-0.62 | $3.97B | $-132M | -3.3% |
| 2024 | $-4.48 | $3.79B | $-910M | -24% |
| 2025 | $-3.00 | $3.68B | $-598M | -16.3% |
| Year | EPS (Avg) | EPS Range | Revenue (Avg) | Revenue Range | Analysts |
|---|---|---|---|---|---|
| 2026 | $1.43 | $1.40 – $1.46 | $3.58B | $3.53B – $3.61B | 12 |
| 2027 | $1.56 | $1.45 – $1.62 | $3.65B | $3.61B – $3.72B | 12 |
| 2028 | $1.73 | $1.05 – $2.32 | $3.76B | $3.75B – $3.77B | 5 |
| 2029 | $1.77 | $1.73 – $1.80 | $3.78B | $3.73B – $3.84B | 1 |
